nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Drosophila model for congenital heart disease
|
Vogler, Georg |
|
2009 |
29-30 |
2 |
p. 47-54 8 p. |
artikel |
2 |
Animal models for diabetes: genes, environment and health
|
Cox, Roger D. |
|
2013 |
29-30 |
2 |
p. e57-e58 nvt p. |
artikel |
3 |
An intensified descending pain-facilitating pathway
|
Pan, Zhizhong Z. |
|
2004 |
29-30 |
2 |
p. 121-125 5 p. |
artikel |
4 |
Cancer
|
Mills, Kevin |
|
2007 |
29-30 |
2 |
p. 45-46 2 p. |
artikel |
5 |
Cancer stem cells
|
Yun, Kyuson |
|
2007 |
29-30 |
2 |
p. 47-52 6 p. |
artikel |
6 |
Cellular and animal models of type 2 diabetes GWAS gene polymorphisms: what can we learn?
|
Rutter, Guy A. |
|
2013 |
29-30 |
2 |
p. e59-e64 nvt p. |
artikel |
7 |
Central plasticity and persistent pain
|
Ko, Shanelle |
|
2004 |
29-30 |
2 |
p. 101-106 6 p. |
artikel |
8 |
Cerebral malaria: Which parasite? Which model?
|
Combes, Valéry |
|
2005 |
29-30 |
2 |
p. 141-147 7 p. |
artikel |
9 |
Chronic models of airway inflammation, mucus hypersecretion and remodelling
|
Jarman, Elizabeth R. |
|
2005 |
29-30 |
2 |
p. 119-126 8 p. |
artikel |
10 |
Clinically related behavioral models: bone cancer pain
|
Sabino, Mary Ann C. |
|
2004 |
29-30 |
2 |
p. 127-134 8 p. |
artikel |
11 |
Contents
|
|
|
2006 |
29-30 |
2 |
p. i- 1 p. |
artikel |
12 |
Contents
|
|
|
2007 |
29-30 |
2 |
p. i- 1 p. |
artikel |
13 |
Contents
|
|
|
2008 |
29-30 |
2 |
p. i- 1 p. |
artikel |
14 |
Contents
|
|
|
2013 |
29-30 |
2 |
p. i- 1 p. |
artikel |
15 |
Contents
|
|
|
2012 |
29-30 |
2 |
p. i- 1 p. |
artikel |
16 |
Contents page
|
|
|
2009 |
29-30 |
2 |
p. i- 1 p. |
artikel |
17 |
Contents page
|
|
|
2004 |
29-30 |
2 |
p. i- 1 p. |
artikel |
18 |
Contents page
|
|
|
2005 |
29-30 |
2 |
p. i- 1 p. |
artikel |
19 |
Disease models for immune and neurological disorders in non-human primates
|
Jonker, Margreet |
|
2008 |
29-30 |
2 |
p. 59-61 3 p. |
artikel |
20 |
Ectodermal dysplasia: Skinny models on the catwalk
|
Duijf, Pascal H.G. |
|
2005 |
29-30 |
2 |
p. 111-118 8 p. |
artikel |
21 |
Editorial
|
|
|
2005 |
29-30 |
2 |
p. iii-iv nvt p. |
artikel |
22 |
Experimental autoimmune encephalomyelitis: A heterogeneous group of animal models to study human multiple sclerosis
|
Teixeira, Simone A. |
|
2005 |
29-30 |
2 |
p. 127-134 8 p. |
artikel |
23 |
Functional characterization of Cdkal1, a risk factor of type 2 diabetes, and the translational opportunities
|
Watanabe, Sayaka |
|
2013 |
29-30 |
2 |
p. e65-e69 nvt p. |
artikel |
24 |
Genes, pathways and metabolism in ageing
|
Slack, Cathy |
|
2013 |
29-30 |
2 |
p. e87-e93 nvt p. |
artikel |
25 |
Genetic models of Candida infection and host resistance factors
|
Ashman, Robert B. |
|
2005 |
29-30 |
2 |
p. 155-159 5 p. |
artikel |
26 |
HIV neuropathy: time for new therapies
|
Brew, B.J. |
|
2004 |
29-30 |
2 |
p. 171-176 6 p. |
artikel |
27 |
How useful are cystic fibrosis mouse models?
|
Egan, Marie E. |
|
2009 |
29-30 |
2 |
p. 35-41 7 p. |
artikel |
28 |
Human embryonic stem cells: A potential system for modeling infant leukemia harboring MLL-AF4 fusion gene
|
Bueno, Clara |
|
2007 |
29-30 |
2 |
p. 53-60 8 p. |
artikel |
29 |
Intrauterine growth retardation – a developmental model of type 2 diabetes
|
Pinney, Sara E. |
|
2013 |
29-30 |
2 |
p. e71-e77 nvt p. |
artikel |
30 |
Modeling cancer patient populations in mice: Complex genetic and environmental factors
|
Radiloff, Daniel R. |
|
2007 |
29-30 |
2 |
p. 83-88 6 p. |
artikel |
31 |
Modeling melanoma
|
Beermann, Friedrich |
|
2006 |
29-30 |
2 |
p. 129-135 7 p. |
artikel |
32 |
Modeling of delayed type hypersensitivity (DTH) in the non-human primate (NHP)
|
Córdoba, Francisco |
|
2008 |
29-30 |
2 |
p. 63-71 9 p. |
artikel |
33 |
Modeling of human prions and prion diseases in vitro and in vivo
|
Zou, Wen-Quan |
|
2004 |
29-30 |
2 |
p. 157-164 8 p. |
artikel |
34 |
Modeling pathogen and host: in vitro, in vivo and in silico models of latent Mycobacterium tuberculosis infection
|
Lin, P. Ling |
|
2005 |
29-30 |
2 |
p. 149-154 6 p. |
artikel |
35 |
Modelling hypothalamic pathways in diabetes and obesity
|
Whittle, Andrew |
|
2013 |
29-30 |
2 |
p. e95-e100 nvt p. |
artikel |
36 |
Models for angiogenesis: From fundamental mechanisms to anticancer treatment research
|
Doumont, Gilles |
|
2007 |
29-30 |
2 |
p. 75-82 8 p. |
artikel |
37 |
Models of acute myeloid leukemia: Prospects for drug development and testing
|
Yin, Bin |
|
2006 |
29-30 |
2 |
p. 137-142 6 p. |
artikel |
38 |
Models of cancer
|
Vlatkovic, Nikolina |
|
2006 |
29-30 |
2 |
p. 127-128 2 p. |
artikel |
39 |
Models of chemotherapy drug-induced peripheral neuropathy
|
Golden, Judith P. |
|
2004 |
29-30 |
2 |
p. 186-191 6 p. |
artikel |
40 |
Models of congenital deafness: Mouse and zebrafish
|
Whitfield, Tanya T. |
|
2005 |
29-30 |
2 |
p. 85-92 8 p. |
artikel |
41 |
Models of contact dermatitis and atopic eczema
|
Gutermuth, Jan |
|
2005 |
29-30 |
2 |
p. 135-140 6 p. |
artikel |
42 |
Models of hematopoietic malignancies: chronic myeloid leukemia
|
Cuiffo, Benjamin |
|
2006 |
29-30 |
2 |
p. 183-189 7 p. |
artikel |
43 |
Models of malignant glioma
|
Aldape, Ken |
|
2006 |
29-30 |
2 |
p. 191-196 6 p. |
artikel |
44 |
Models of ovarian cancer metastasis: Murine models
|
Šale, Sanja |
|
2006 |
29-30 |
2 |
p. 149-154 6 p. |
artikel |
45 |
Models of reactive oxygen species in cancer
|
Lu, Weiqin |
|
2007 |
29-30 |
2 |
p. 67-73 7 p. |
artikel |
46 |
Models of signal transduction in cancer
|
Li, Dongguang |
|
2007 |
29-30 |
2 |
p. 61-66 6 p. |
artikel |
47 |
Model systems for neurofibroma and malignant peripheral nerve sheath tumor
|
Ratner, Nancy |
|
2006 |
29-30 |
2 |
p. 175-182 8 p. |
artikel |
48 |
Mouse models for Type 1 Diabetes
|
Van Belle, T.L. |
|
2009 |
29-30 |
2 |
p. 41-45 5 p. |
artikel |
49 |
Mouse models of β-cell KATP channel dysfunction
|
Brereton, Melissa F. |
|
2013 |
29-30 |
2 |
p. e101-e109 nvt p. |
artikel |
50 |
Mouse models of Down syndrome
|
Davisson, Muriel T. |
|
2005 |
29-30 |
2 |
p. 103-109 7 p. |
artikel |
51 |
Nervous system cancer models: Medulloblastoma
|
Hatton, Beryl A. |
|
2006 |
29-30 |
2 |
p. 167-174 8 p. |
artikel |
52 |
New insights in the regulation of skeletal muscle PGC-1α by exercise and metabolic diseases
|
Pérez-Schindler, Joaquín |
|
2013 |
29-30 |
2 |
p. e79-e85 nvt p. |
artikel |
53 |
Non-human primate models for Parkinson's disease
|
Philippens, Ingrid H.C.H.M. |
|
2008 |
29-30 |
2 |
p. 105-111 7 p. |
artikel |
54 |
Non-human primate models in allo-transplantation research
|
Haanstra, Krista G. |
|
2008 |
29-30 |
2 |
p. 73-79 7 p. |
artikel |
55 |
Non-human primate models of multiple sclerosis
|
’t Hart, Bert A. |
|
2008 |
29-30 |
2 |
p. 97-104 8 p. |
artikel |
56 |
Opportunities for neuroprotection in ALS using cell death mechanism rationales
|
Martin, Lee J. |
|
2004 |
29-30 |
2 |
p. 135-143 9 p. |
artikel |
57 |
Organotypic cultures represent tumor microenvironment for drug testing
|
Benbrook, Doris M. |
|
2006 |
29-30 |
2 |
p. 143-148 6 p. |
artikel |
58 |
Pediatric diseases: future action?
|
Haddad, Gabriel G. |
|
2009 |
29-30 |
2 |
p. 33-34 2 p. |
artikel |
59 |
Perspectives on models of spinal muscular atrophy for drug discovery
|
Butchbach, Matthew E.R. |
|
2004 |
29-30 |
2 |
p. 151-156 6 p. |
artikel |
60 |
Poly(ADP-ribose) polymerase (PARP) and PARP inhibitors
|
Curtin, Nicola J. |
|
2012 |
29-30 |
2 |
p. e51-e58 nvt p. |
artikel |
61 |
Preclinical evaluation of anti-rheumatic drugs in a non-human primate model of arthritic disease
|
Vierboom, Michel P.M. |
|
2008 |
29-30 |
2 |
p. 89-95 7 p. |
artikel |
62 |
Recent developments in models of amyotrophy lateral sclerosis
|
Ackerley, Steven |
|
2004 |
29-30 |
2 |
p. 165-169 5 p. |
artikel |
63 |
Recent progress in Alzheimer's disease: animal models lead the way
|
Li, Tong |
|
2004 |
29-30 |
2 |
p. 145-149 5 p. |
artikel |
64 |
Regeneration and functional recovery following peripheral nerve injury
|
Rodríguez, Francisco J. |
|
2004 |
29-30 |
2 |
p. 177-185 9 p. |
artikel |
65 |
Rodent models clarify the role of cells expressing the substance P receptor in pain
|
Carrasquillo, Yarimar |
|
2004 |
29-30 |
2 |
p. 107-113 7 p. |
artikel |
66 |
Rodent models for autism: A critical review
|
Belzung, Catherine |
|
2005 |
29-30 |
2 |
p. 93-101 9 p. |
artikel |
67 |
Targeting DNA repair
|
Damia, Giovanna |
|
2012 |
29-30 |
2 |
p. e39-e41 nvt p. |
artikel |
68 |
Targeting mismatch repair: a challenge for personalized chemotherapy
|
Pichierri, Pietro |
|
2012 |
29-30 |
2 |
p. e43-e50 nvt p. |
artikel |
69 |
Telomeres and telomerase in aging and cancer: Lessons learned from experimental model systems
|
Poynter, Kennon R. |
|
2006 |
29-30 |
2 |
p. 155-160 6 p. |
artikel |
70 |
The cAMP pathway and pain: potential targets for drug development
|
Skyba, David A. |
|
2004 |
29-30 |
2 |
p. 115-119 5 p. |
artikel |
71 |
The DNA damage response to monofunctional anticancer DNA binders
|
Soares, Daniele G. |
|
2012 |
29-30 |
2 |
p. e59-e67 nvt p. |
artikel |
72 |
The interaction of EGFR and repair of DNA damage following chemotherapy and radiation
|
Hochhauser, Daniel |
|
2012 |
29-30 |
2 |
p. e69-e73 nvt p. |
artikel |
73 |
Tumorigenesis: Modeling Kras in cells and mice
|
Gurumurthy, Sushma |
|
2006 |
29-30 |
2 |
p. 161-166 6 p. |
artikel |
74 |
Xenotransplantation
|
Schuurman, Henk-Jan |
|
2008 |
29-30 |
2 |
p. 81-87 7 p. |
artikel |